933 related articles for article (PubMed ID: 27858286)
1. Hypoxic Preconditioning Augments the Therapeutic Efficacy of Bone Marrow Stromal Cells in a Rat Ischemic Stroke Model.
Chen J; Yang Y; Shen L; Ding W; Chen X; Wu E; Cai K; Wang G
Cell Mol Neurobiol; 2017 Aug; 37(6):1115-1129. PubMed ID: 27858286
[TBL] [Abstract][Full Text] [Related]
2. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
[TBL] [Abstract][Full Text] [Related]
3. Sodium ferulate and n-butylidenephthalate combined with bone marrow stromal cells (BMSCs) improve the therapeutic effects of angiogenesis and neurogenesis after rat focal cerebral ischemia.
Zhang Q; Zhao Y; Xu Y; Chen Z; Liu N; Ke C; Liu B; Wu W
J Transl Med; 2016 Jul; 14(1):223. PubMed ID: 27465579
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats.
Wei L; Fraser JL; Lu ZY; Hu X; Yu SP
Neurobiol Dis; 2012 Jun; 46(3):635-45. PubMed ID: 22426403
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of MCI-186 on transplantation of bone marrow stromal cells in rat ischemic stroke model.
Shen LH; Ye M; Ding XS; Han Q; Zhang C; Liu XF; Huang H; Wu EB; Huang HF; Gu XS
Neuroscience; 2012 Oct; 223():315-24. PubMed ID: 22885235
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic preconditioning enhances the differentiation of bone marrow stromal cells into mature oligodendrocytes via the mTOR/HIF-1α/VEGF pathway in traumatic brain injury.
Yuan X; Luo Q; Shen L; Chen J; Gan D; Sun Y; Ding L; Wang G
Brain Behav; 2020 Jul; 10(7):e01675. PubMed ID: 32475084
[TBL] [Abstract][Full Text] [Related]
7. Preconditioning of bone marrow mesenchymal stem cells with hydrogen sulfide improves their therapeutic potential.
Zhang Q; Liu S; Li T; Yuan L; Liu H; Wang X; Wang F; Wang S; Hao A; Liu D; Wang Z
Oncotarget; 2016 Sep; 7(36):58089-58104. PubMed ID: 27517324
[TBL] [Abstract][Full Text] [Related]
8. Preconditioning of bone marrow-derived mesenchymal stromal cells by tetramethylpyrazine enhances cell migration and improves functional recovery after focal cerebral ischemia in rats.
Li L; Chu L; Fang Y; Yang Y; Qu T; Zhang J; Yin Y; Gu J
Stem Cell Res Ther; 2017 May; 8(1):112. PubMed ID: 28499457
[TBL] [Abstract][Full Text] [Related]
9. Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice.
Song M; Mohamad O; Gu X; Wei L; Yu SP
Cell Transplant; 2013; 22(11):2001-15. PubMed ID: 23069268
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic preconditioning increases the protective effect of bone marrow mesenchymal stem cells on spinal cord ischemia/reperfusion injury.
Wang Z; Fang B; Tan Z; Zhang D; Ma H
Mol Med Rep; 2016 Mar; 13(3):1953-60. PubMed ID: 26783161
[TBL] [Abstract][Full Text] [Related]
11. Possible Mechanism of Therapeutic Effect of 3-Methyl-1-phenyl-2-pyrazolin-5-one and Bone Marrow Stromal Cells Combination Treatment in Rat Ischemic Stroke Model.
Shen LH; Chen J; Shen HC; Ye M; Liu XF; Ding WS; Sheng YF; Ding XS
Chin Med J (Engl); 2016 Jun; 129(12):1471-6. PubMed ID: 27270545
[TBL] [Abstract][Full Text] [Related]
12. Delayed and repeated intranasal delivery of bone marrow stromal cells increases regeneration and functional recovery after ischemic stroke in mice.
Chau MJ; Deveau TC; Gu X; Kim YS; Xu Y; Yu SP; Wei L
BMC Neurosci; 2018 Apr; 19(1):20. PubMed ID: 29649974
[TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice.
Sun J; Wei ZZ; Gu X; Zhang JY; Zhang Y; Li J; Wei L
Exp Neurol; 2015 Oct; 272():78-87. PubMed ID: 25797577
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Effects of Brain-Derived Neurotrophic Factor and Noggin-Modified Bone Mesenchymal Stem Cells in Focal Cerebral Ischemia in Rats.
Lu H; Liu X; Zhang N; Zhu X; Liang H; Sun L; Cheng Y
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):410-8. PubMed ID: 26654668
[TBL] [Abstract][Full Text] [Related]
15. The paracrine effect of cobalt chloride on BMSCs during cognitive function rescue in the HIBD rat.
Dai Y; Li W; Zhong M; Chen J; Cheng Q; Liu Y; Li T
Behav Brain Res; 2017 Aug; 332():99-109. PubMed ID: 28576310
[TBL] [Abstract][Full Text] [Related]
16. miR-145 Regulates Diabetes-Bone Marrow Stromal Cell-Induced Neurorestorative Effects in Diabetes Stroke Rats.
Cui C; Ye X; Chopp M; Venkat P; Zacharek A; Yan T; Ning R; Yu P; Cui G; Chen J
Stem Cells Transl Med; 2016 Dec; 5(12):1656-1667. PubMed ID: 27460851
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial intranasal delivery of bone marrow mesenchymal stem cells and insulin-like growth factor-1 improves neurovascularization and functional outcomes following focal cerebral ischemia in mice.
Shen H; Gu X; Wei ZZ; Wu A; Liu X; Wei L
Exp Neurol; 2021 Mar; 337():113542. PubMed ID: 33275952
[TBL] [Abstract][Full Text] [Related]
18. Promoting therapeutic angiogenesis of focal cerebral ischemia using thrombospondin-4 (TSP4) gene-modified bone marrow stromal cells (BMSCs) in a rat model.
Zhang Q; Zhou M; Wu X; Li Z; Liu B; Gao W; Yue J; Liu T
J Transl Med; 2019 Apr; 17(1):111. PubMed ID: 30947736
[TBL] [Abstract][Full Text] [Related]
19. Preconditioning with Trehalose Protects the Bone Marrow-Derived Mesenchymal Stem Cells Under Oxidative Stress and Enhances the Stem Cell-Based Therapy for Cerebral Ischemic Stroke.
Shu B; Wan J; Li X; Liu R; Xu C; An Y; Chen J
Cell Reprogram; 2022 Jun; 24(3):118-131. PubMed ID: 35647904
[TBL] [Abstract][Full Text] [Related]
20. Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats.
Liu XB; Wang JA; Ji XY; Yu SP; Wei L
Stem Cell Res Ther; 2014 Sep; 5(5):111. PubMed ID: 25257482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
